Skip to main navigation Skip to search Skip to main content

Selective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)S165-S172
JournalNeuro-Oncology
Volume26
Issue numberSupplement_2
DOIs
StatePublished - Apr 1 2024

ASJC Scopus Subject Areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Keywords

  • ClpP
  • DRD2
  • H3 K27M-mutant glioma
  • non-midline H3 K27M-mutant glioma
  • ONC201

Cite this